APLS logo

Apellis Pharmaceuticals (APLS) Cash from operations

annual CFO:

-$87.87M+$506.87M(+85.23%)
December 31, 2024

Summary

  • As of today (June 28, 2025), APLS annual cash flow from operations is -$87.87 million, with the most recent change of +$506.87 million (+85.23%) on December 31, 2024.
  • During the last 3 years, APLS annual CFO has risen by +$475.26 million (+84.40%).
  • APLS annual CFO is now -2450.76% below its all-time high of -$3.44 million, reached on December 31, 2013.

Performance

APLS Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

quarterly CFO:

-$53.41M-$72.77M(-375.88%)
March 31, 2025

Summary

  • As of today (June 28, 2025), APLS quarterly cash flow from operations is -$53.41 million, with the most recent change of -$72.77 million (-375.88%) on March 31, 2025.
  • Over the past year, APLS quarterly CFO has increased by +$79.57 million (+59.84%).
  • APLS quarterly CFO is now -137.62% below its all-time high of $141.98 million, reached on December 31, 2020.

Performance

APLS quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

TTM CFO:

-$8.29M+$79.57M(+90.56%)
March 31, 2025

Summary

  • As of today (June 28, 2025), APLS TTM cash flow from operations is -$8.29 million, with the most recent change of +$79.57 million (+90.56%) on March 31, 2025.
  • Over the past year, APLS TTM CFO has increased by +$541.80 million (+98.49%).
  • APLS TTM CFO is now at all-time high.

Performance

APLS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLScash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

APLS Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+85.2%+59.8%+98.5%
3 y3 years+84.4%+52.1%+98.4%
5 y5 years+58.4%+50.7%+97.1%

APLS Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+85.2%-256.6%+69.9%at high+98.7%
5 y5-yearat high+85.2%-137.6%+69.9%at high+98.7%
alltimeall time-2450.8%+85.2%-137.6%+69.9%at high+98.7%

APLS Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$53.41M(-375.9%)
-$8.29M(-90.6%)
Dec 2024
-$87.87M(-85.2%)
$19.36M(-43.2%)
-$87.87M(-57.2%)
Sep 2024
-
$34.10M(-508.9%)
-$205.10M(-49.8%)
Jun 2024
-
-$8.34M(-93.7%)
-$408.28M(-25.8%)
Mar 2024
-
-$132.98M(+35.9%)
-$550.10M(-7.5%)
Dec 2023
-$594.74M(+15.8%)
-$97.88M(-42.1%)
-$594.74M(-6.7%)
Sep 2023
-
-$169.09M(+12.6%)
-$637.60M(+2.4%)
Jun 2023
-
-$150.16M(-15.5%)
-$622.94M(+7.4%)
Mar 2023
-
-$177.62M(+26.2%)
-$579.80M(+12.9%)
Dec 2022
-$513.75M(-8.8%)
-$140.74M(-8.9%)
-$513.75M(+5.8%)
Sep 2022
-
-$154.42M(+44.3%)
-$485.50M(-2.8%)
Jun 2022
-
-$107.02M(-4.1%)
-$499.71M(-4.2%)
Mar 2022
-
-$111.56M(-0.8%)
-$521.37M(-7.4%)
Dec 2021
-$563.13M(+250.9%)
-$112.50M(-33.3%)
-$563.13M(+82.4%)
Sep 2021
-
-$168.63M(+31.0%)
-$308.65M(+28.7%)
Jun 2021
-
-$128.69M(-16.1%)
-$239.85M(+16.7%)
Mar 2021
-
-$153.31M(-208.0%)
-$205.45M(+28.0%)
Dec 2020
-$160.49M
$141.98M(-242.2%)
-$160.49M(-58.3%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$99.82M(+5.9%)
-$384.54M(+13.7%)
Jun 2020
-
-$94.29M(-13.0%)
-$338.31M(+19.2%)
Mar 2020
-
-$108.35M(+32.0%)
-$283.92M(+34.5%)
Dec 2019
-$211.13M(+60.9%)
-$82.07M(+53.1%)
-$211.13M(+21.7%)
Sep 2019
-
-$53.60M(+34.3%)
-$173.54M(+13.4%)
Jun 2019
-
-$39.91M(+12.2%)
-$153.08M(+6.4%)
Mar 2019
-
-$35.56M(-20.1%)
-$143.87M(+9.6%)
Dec 2018
-$131.24M(+181.7%)
-$44.48M(+34.2%)
-$131.24M(+28.3%)
Sep 2018
-
-$33.13M(+7.9%)
-$102.30M(+27.4%)
Jun 2018
-
-$30.69M(+33.8%)
-$80.30M(+31.4%)
Mar 2018
-
-$22.94M(+47.7%)
-$61.10M(+31.1%)
Dec 2017
-$46.60M(+79.2%)
-$15.53M(+39.5%)
-$46.60M(+50.0%)
Sep 2017
-
-$11.14M(-3.1%)
-$31.06M(+55.9%)
Jun 2017
-
-$11.50M(+36.4%)
-$19.92M(+136.4%)
Mar 2017
-
-$8.43M
-$8.43M
Dec 2016
-$26.00M(+37.9%)
-
-
Dec 2015
-$18.86M(+89.6%)
-
-
Dec 2014
-$9.95M(+188.8%)
-
-
Dec 2013
-$3.44M
-
-

FAQ

  • What is Apellis Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual CFO year-on-year change?
  • What is Apellis Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly CFO year-on-year change?
  • What is Apellis Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals TTM CFO year-on-year change?

What is Apellis Pharmaceuticals annual cash flow from operations?

The current annual CFO of APLS is -$87.87M

What is the all time high annual CFO for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual cash flow from operations is -$3.44M

What is Apellis Pharmaceuticals annual CFO year-on-year change?

Over the past year, APLS annual cash flow from operations has changed by +$506.87M (+85.23%)

What is Apellis Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of APLS is -$53.41M

What is the all time high quarterly CFO for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly cash flow from operations is $141.98M

What is Apellis Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, APLS quarterly cash flow from operations has changed by +$79.57M (+59.84%)

What is Apellis Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of APLS is -$8.29M

What is the all time high TTM CFO for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high TTM cash flow from operations is -$8.29M

What is Apellis Pharmaceuticals TTM CFO year-on-year change?

Over the past year, APLS TTM cash flow from operations has changed by +$541.80M (+98.49%)
On this page